These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27828908)

  • 1. USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
    Andreuzzi P; Fishman GA; Anderson RJ
    Retina; 2017 Aug; 37(8):1555-1561. PubMed ID: 27828908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
    Genead MA; Fishman GA; Walia S
    Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
    Verbakel SK; van de Ven JP; Le Blanc LM; Groenewoud JM; de Jong EK; Klevering BJ; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5143-5147. PubMed ID: 27699410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Carbonic Anhydrase Inhibitors on Cystoid Fluid Collections and Visual Acuity in Patients with X-Linked Retinoschisis.
    Hensman J; Hahn LC; van Schooneveld MJ; Diederen RMH; Ten Brink JB; Florijn RJ; Bergen AA; Strubbe I; Heutinck P; van Genderen MM; van den Born LI; Thiadens AA; de Zaeytijd J; Leroy BP; Hoyng CB; Boon CJF
    Ophthalmol Retina; 2024 Jun; 8(6):600-606. PubMed ID: 38104928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
    Thobani A; Fishman GA
    Retina; 2011 Feb; 31(2):312-5. PubMed ID: 20966823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
    Grover S; Fishman GA; Fiscella RG; Adelman AE
    Retina; 1997; 17(3):222-31. PubMed ID: 9196934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
    Genead MA; Fishman GA
    Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of dorzolamide for patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA
    Retina; 2006 Sep; 26(7):741-5. PubMed ID: 16963845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide in the treatment of X-linked retinoschisis maculopathy.
    Ghajarnia M; Gorin MB
    Arch Ophthalmol; 2007 Apr; 125(4):571-3. PubMed ID: 17420384
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Topical Brinzolamide Treatment in Posterior Microphthalmos-Related Macular Cystoid Lesions: A Case Series.
    Durmaz Engin C; Ekinci UB; Selver A; Saatci AO
    Turk J Ophthalmol; 2020 Mar; 50(1):44-49. PubMed ID: 32167263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of topical and systemic carbonic anhydrase in the treatment of chromosome X-linked retinoschisis.
    Rocha Cabrera P; Pareja Ríos AC; Cordovés Dorta L; Mantolán Sarmiento C; Serrano García MA
    Arch Soc Esp Oftalmol; 2014 Aug; 89(8):320-3. PubMed ID: 24269421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors in patients with X-linked retinoschisis: effects on macular morphology and function.
    Testa F; Di Iorio V; Gallo B; Marchese M; Nesti A; De Rosa G; Melillo P; Simonelli F
    Ophthalmic Genet; 2019 Jun; 40(3):207-212. PubMed ID: 31149861
    [No Abstract]   [Full Text] [Related]  

  • 13. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
    Liew G; Moore AT; Webster AR; Michaelides M
    Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE.
    Pepple KL; Nguyen MH; Pakzad-Vaezi K; Williamson K; Odell N; Lee C; Leveque TK; Van Gelder RN
    Retina; 2019 May; 39(5):948-955. PubMed ID: 29346240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of optical coherence tomography findings with visual acuity and macular lesions in patients with X-linked retinoschisis.
    Apushkin MA; Fishman GA; Janowicz MJ
    Ophthalmology; 2005 Mar; 112(3):495-501. PubMed ID: 15745780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)].
    Schilling H; Pauleikhoff D; Schrenk M; Wessing A
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):206-11. PubMed ID: 8510414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical brinzolamide for foveal schisis in juvenile retinoschisis.
    Yang FP; Willyasti K; Leo SW
    J AAPOS; 2013 Apr; 17(2):225-7. PubMed ID: 23541677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
    Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y
    Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228
    [No Abstract]   [Full Text] [Related]  

  • 20. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.